An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Vaccines

FluMist Quadrivalent

STN: 125020
Proper Name: Influenza Vaccine
Tradename: FluMist Quadrivalent
Manufacturer: MedImmune
Indications:

For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

Product Information

Package Insert - FluMist Quadrivalent

Supporting Documents

January 12, 2023 Approval Letter - FluMist
July 27, 2022 Approval Letter - FluMist Quadrivalent
July 20, 2021 Approval Letter - FluMist
July 9, 2020 Approval Letter - FluMist
April 14, 2020 Approval Letter - FluMist
July 15, 2019 Approval Letter - FluMist
February 28, 2019 Approval Letter - FluMist Quadrivalent
To remove information from the Use in Specific Populations section of the Highlights of Prescribing Information of the package insert (PI) for clarity.
August 10, 2018 Approval Letter - FluMist Quadrivalent
To include the 2018-2019 United States formulation and associated labeling revisions.
May 15, 2018 Approval Letter - FluMist Quadrivalent
To revise package insert to comply with Pregnancy and Lactation Labeling Rule.
March 17, 2017 Approval Letter - FluMist Quadrivalent
To revise the Ovalbumin test release specification and make the associated changes to the labeling.
Supporting Documents older than three years - FluMist Quadrivalent

Related Information

Top